Revenue
2023
2024
2025
Connect Biopharma Holdings Ltd (CNTB)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $64,000 | $26.0M | $0 | — | — |
| Research & development | $37.8M | $29.3M | $53.0M | $96.6M | $80.5M |
| Operating expenses | $58.1M | $48.5M | $69.1M | — | — |
| Operating income | −$58.1M | −$22.5M | −$69.1M | −$119.3M | −$98.1M |
| EBITDAderived | −$57.4M | −$21.8M | −$68.3M | −$118.3M | −$97.5M |
| Net income | −$55.5M | −$15.6M | −$62.1M | −$118.1M | −$202.3M |
| Basic EPSper diluted share | -$1.00 | -$0.28 | -$1.13 | -$2.15 | -$3.88 |
| Diluted EPSper diluted share | -$1.00 | -$0.28 | -$1.13 | -$2.15 | -$3.88 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026Form 4 | Huang JamesDirector | BuyOrdinary Shares · indirect | 150.0K | $2.48 | $372.0K | 13.31M |
| Mar 31, 2026Form 4 | Huang JamesDirector | BuyOrdinary Shares · indirect | 1.16M | $3.45 | $4.00M | 13.16M |